Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 42

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 42
---
 Split will terminate and the
Reverse Stock Split Charter Amendment will be abandoned.

The market price of our Common
Stock is dependent upon our performance and other factors, some of which are unrelated to the number of shares outstanding. If the Reverse
Stock Split is effected and the market price of our Common Stock declines, the percentage decline as an absolute number and as a percentage
of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split. Furthermore, the reduced
number of shares that will be outstanding after the Reverse Stock Split could significantly reduce the trading volume and otherwise adversely
affect the liquidity of our Common Stock.

We have not proposed the
Reverse Stock Split in response to any effort of which we are aware to accumulate our shares of Common Stock or obtain control of the
Company, nor is it a plan by management to recommend a series of similar actions to our Board or our stockholders. Notwithstanding the
decrease in the number of outstanding shares of Common Stock following the Reverse Stock Split, our Board does not intend for this transaction
to be the first step in a “going private transaction” within the meaning of Rule 13e-3 of the Exchange Act.

Effects of the Reverse Stock Split

Effects of the Reverse Stock Split on Issued and Outstanding Shares.

If the Reverse Stock Split is effected, it will reduce the total number
of issued and outstanding shares of Common Stock, including shares held by the Company as treasury shares, by a Reverse Stock Split ratio
of 1-for-250 to 1-for-500. Accordingly, each of our stockholders will own fewer shares of Common Stock as a result of the Reverse Stock
Split. However, the Reverse Stock Split will affect all stockholders uniformly and will not affect any stockholder’s percentage
ownership interest in the Company, except to the extent that the Reverse Stock Split would result in an adjustment to a stockholder’s
ownership of Common Stock due to the treatment of fractional shares in the Reverse Stock Split. Therefore, voting rights and other rights
and preferences of the holders of Common Stock will not be affected by the Reverse Stock Split (other than as a result of the treatment
of fractional shares). Common stock issued pursuant to the Reverse Stock Split will remain fully paid and nonassessable, and the par value
per share of Common Stock will remain $0.0001.

<div align='center'>26</div>

As of the Record Date, the Company had 29,929,668 shares of Common
Stock